Literature DB >> 16537807

G-CSF down-regulation of CXCR4 expression identified as a mechanism for mobilization of myeloid cells.

Hyun Kyung Kim1, Maria De La Luz Sierra, Cassin Kimmel Williams, A Virginia Gulino, Giovanna Tosato.   

Abstract

CXCR4 receptor expression is required for the retention of granulocyte precursors and mature neutrophils within the bone marrow, and disruption of the SDF-1/CXCR4 axis in the bone marrow results in the mobilization of myeloid lineage cells to the peripheral circulation. We report that G-CSF down-regulates CXCR4 expression in bone marrow-derived murine and human myeloid lineage cells. When exposed to G-CSF, murine Gr1(+) bone marrow myeloid cells display a time-dependent reduction of cell-surface CXCR4 and respond poorly to SDF-1 in attachment and migration assays. Bone marrow-derived cells of nonmyeloid lineage display no change in surface CXCR4 expression upon exposure to G-CSF. Compared with controls, mice treated with G-CSF for mobilization of hematopoietic progenitor cells display reduced levels of CXCR4 selectively in bone marrow Gr1(+) myeloid cells. Since bone marrow myeloid cells express G-CSF receptors and G-CSF rapidly reduces CXCR4 expression in purified Gr1(+) cells populations, these results provide evidence that G-CSF acts directly on myeloid lineage cells to reduce CXCR4 expression. By down-regulating CXCR4 expression in bone marrow myeloid cells and attenuating their responsiveness to SDF-1, G-CSF promotes their mobilization from the bone marrow to the peripheral blood.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16537807      PMCID: PMC1895847          DOI: 10.1182/blood-2005-10-4162

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  49 in total

1.  Functional regeneration following spinal transection demonstrated in the isolated spinal cord of the larval sea lamprey.

Authors:  A H Cohen; S A Mackler; M E Selzer
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

2.  HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor.

Authors:  Y Feng; C C Broder; P E Kennedy; E A Berger
Journal:  Science       Date:  1996-05-10       Impact factor: 47.728

3.  Identification of the human analogue of a regulator that induces differentiation in murine leukaemic cells.

Authors:  N A Nicola; C G Begley; D Metcalf
Journal:  Nature       Date:  1985 Apr 18-24       Impact factor: 49.962

4.  Purification and characterization of the receptor for murine granulocyte colony-stimulating factor.

Authors:  R Fukunaga; E Ishizaka-Ikeda; S Nagata
Journal:  J Biol Chem       Date:  1990-08-15       Impact factor: 5.157

5.  Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells.

Authors:  K Hestdal; F W Ruscetti; J N Ihle; S E Jacobsen; C M Dubois; W C Kopp; D L Longo; J R Keller
Journal:  J Immunol       Date:  1991-07-01       Impact factor: 5.422

6.  The kinetics of murine hematopoietic stem cells in vivo in response to prolonged increased mature blood cell production induced by granulocyte colony-stimulating factor.

Authors:  G de Haan; B Dontje; C Engel; M Loeffler; W Nijhof
Journal:  Blood       Date:  1995-10-15       Impact factor: 22.113

7.  Characterization of hematopoietic progenitor mobilization in protease-deficient mice.

Authors:  Jean-Pierre Levesque; Fulu Liu; Paul J Simmons; Tomoko Betsuyaku; Robert M Senior; Christine Pham; Daniel C Link
Journal:  Blood       Date:  2004-03-09       Impact factor: 22.113

8.  Molecular cloning and expression of cDNA for human granulocyte colony-stimulating factor.

Authors:  S Nagata; M Tsuchiya; S Asano; Y Kaziro; T Yamazaki; O Yamamoto; Y Hirata; N Kubota; M Oheda; H Nomura
Journal:  Nature       Date:  1986 Jan 30-Feb 5       Impact factor: 49.962

9.  GRK6 deficiency is associated with enhanced CXCR4-mediated neutrophil chemotaxis in vitro and impaired responsiveness to G-CSF in vivo.

Authors:  Anne Vroon; Cobi J Heijnen; Roel Raatgever; Ivo P Touw; Rob E Ploemacher; Richard T Premont; Annemieke Kavelaars
Journal:  J Leukoc Biol       Date:  2004-01-02       Impact factor: 4.962

10.  Altered leukocyte response to CXCL12 in patients with warts hypogammaglobulinemia, infections, myelokathexis (WHIM) syndrome.

Authors:  Anna Virginia Gulino; Daniele Moratto; Silvano Sozzani; Patrizia Cavadini; Karel Otero; Laura Tassone; Luisa Imberti; Silvia Pirovano; Lucia D Notarangelo; Roberta Soresina; Evelina Mazzolari; David L Nelson; Luigi D Notarangelo; Raffaele Badolato
Journal:  Blood       Date:  2004-03-16       Impact factor: 22.113

View more
  75 in total

Review 1.  Peeking into the secret life of neutrophils.

Authors:  Jackson LiangYao Li; Lai Guan Ng
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

2.  A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia.

Authors:  Geoffrey L Uy; Michael P Rettig; Ibraheem H Motabi; Kyle McFarland; Kathryn M Trinkaus; Lindsay M Hladnik; Shashikant Kulkarni; Camille N Abboud; Amanda F Cashen; Keith E Stockerl-Goldstein; Ravi Vij; Peter Westervelt; John F DiPersio
Journal:  Blood       Date:  2012-02-02       Impact factor: 22.113

3.  MicroRNA126 contributes to granulocyte colony-stimulating factor-induced hematopoietic progenitor cell mobilization by reducing the expression of vascular cell adhesion molecule 1.

Authors:  Ombretta Salvucci; Kan Jiang; Paola Gasperini; Dragan Maric; Jinfang Zhu; Shuhei Sakakibara; Georgina Espigol-Frigole; Shushang Wang; Giovanna Tosato
Journal:  Haematologica       Date:  2012-01-22       Impact factor: 9.941

4.  WHIM syndrome myelokathexis reproduced in the NOD/SCID mouse xenotransplant model engrafted with healthy human stem cells transduced with C-terminus-truncated CXCR4.

Authors:  Toshinao Kawai; Uimook Choi; Lanise Cardwell; Suk See DeRavin; Nora Naumann; Narda L Whiting-Theobald; Gilda F Linton; Jaehyun Moon; Philip M Murphy; Harry L Malech
Journal:  Blood       Date:  2006-08-31       Impact factor: 22.113

5.  CXCR4 is a key regulator of neutrophil release from the bone marrow under basal and stress granulopoiesis conditions.

Authors:  Kyle J Eash; Jacquelyn M Means; Douglas W White; Daniel C Link
Journal:  Blood       Date:  2009-03-05       Impact factor: 22.113

6.  Early TGF-β inhibition in mice reduces the incidence of breast cancer induced bone disease in a myeloid dependent manner.

Authors:  Denise Buenrostro; Kristin A Kwakwa; Nicole E Putnam; Alyssa R Merkel; Joshua R Johnson; James E Cassat; Julie A Sterling
Journal:  Bone       Date:  2018-05-16       Impact factor: 4.398

7.  Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML.

Authors:  Zhihong Zeng; Yue Xi Shi; Ismael J Samudio; Rui-Yu Wang; Xiaoyang Ling; Olga Frolova; Mark Levis; Joshua B Rubin; Robert R Negrin; Elihu H Estey; Sergej Konoplev; Michael Andreeff; Marina Konopleva
Journal:  Blood       Date:  2008-10-27       Impact factor: 22.113

Review 8.  Genetic heterogeneity in severe congenital neutropenia: how many aberrant pathways can kill a neutrophil?

Authors:  Alejandro A Schäffer; Christoph Klein
Journal:  Curr Opin Allergy Clin Immunol       Date:  2007-12

9.  Blocking CXCR4 alleviates desmoplasia, increases T-lymphocyte infiltration, and improves immunotherapy in metastatic breast cancer.

Authors:  Ivy X Chen; Vikash P Chauhan; Jessica Posada; Mei R Ng; Michelle W Wu; Pichet Adstamongkonkul; Peigen Huang; Neal Lindeman; Robert Langer; Rakesh K Jain
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-30       Impact factor: 11.205

10.  Pharmacokinetic and pharmacodynamic modelling of the novel human granulocyte colony-stimulating factor derivative Maxy-G34 and pegfilgrastim in rats.

Authors:  M Scholz; C Engel; D Apt; S L Sankar; E Goldstein; M Loeffler
Journal:  Cell Prolif       Date:  2009-09-24       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.